SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: May 2, 1997
MILLIPORE CORPORATION
(Exact name of registrant as specified in its charter)
Massachusetts 0-1052 04-2170233
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation or No.)
organization)
80 Ashby Road, Bedford, Massachusetts 01730
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 275-9200
Item 5. Other Events
On May 2, 1997, the Environmental Quality Board (EQB) of
Puerto Rico served an administrative order on Millipore Cidra,
Inc., a wholly-owned subsidiary of Millipore Corporation (the
Registrant). The administrative order alleges: (i) that the
nitrocellulose filter membrane scrap produced by Millipore
Cidra's manufacturing operations is a hazardous waste as defined
in EQB regulations; (ii) that Millipore Cidra, Inc. failed to
manage the nitrocellulose membrane scrap as a hazardous waste;
and (iii) that such failure violated EQB regulations. The EQB
has proposed a fine of $96.5 million against Millipore Cidra, Inc.
On May 5, 1997 the Registrant issued a press release
commenting on the administrative order received by Millipore
Cidra, Inc.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit 99 Press Release dated May 5, 1997
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
MILLIPORE CORPORATION
(Registrant)
Date: May 6, 1997 /s/ Michael P. Carroll
Michael P. Carroll
Vice President and Chief Financial
Officer
EXHIBIT 99: Press Release dated May 5, 1997
For Immediate Release
Investor Contact: Media Contact:
Geoffrey Helliwell Tom Anderson
Director, Treasury Operations Director, Corporate
Communications
(617) 533-2032 (617) 533-2225
(800) 225-3384 (800) 225-3384
[email protected] [email protected]
Millipore Comments On Administrative Order
By Environmental Quality Board Of Puerto Rico
Bedford, Massachusetts, May 5, 1997 -- Millipore Corporation
(NYSE/MIL) today issued the following statement with respect to
an administrative order received by its wholly-owned subsidiary,
Millipore Cidra, Inc., from the Environmental Quality Board of
Puerto Rico.
Millipore Cidra stated that membrane scrap from its production of
nitrocellulose-based membrane is not a hazardous waste. The
Company believes that good science should prevail in this matter
and expects to achieve timely and favorable resolution of this
issue.
After the close of business Friday, May 2, the EQB served an
administrative order alleging that membrane scrap discarded
during the production of Millipore Cidra's nitrocellulose-based
membrane is a hazardous waste. The EQB proposes a fine of $96.5
million against Millipore Cidra, Inc. However, the Company's
experience in manufacturing and handling the membrane scrap,
supported by analytical tests performed in accordance with
applicable U.S. Environmental Protection Agency and EQB
regulations show that such waste is not a hazardous waste under
such regulations.
Millipore Cidra, Inc., based in Cidra, Puerto Rico, employs 310
persons and has operated in Puerto Rico for twenty years.
Millipore Corporation, its parent company, has an established
health, safety and environmental policy which has been adopted by
Millipore Cidra, Inc.
Millipore Cidra's nitrocellulose-based membrane is a specialized
filter used across a wide range of research and commercial
applications. Examples of such uses include the filtering of
fluids used in the production of pharmaceutical products, water
testing and quality control processes for consumer beverages.
Millipore produces over 50 filtration materials, in addition to
the nitrocellulose-based membrane.
Millipore is a multinational high technology company that applies
its purification technology to critical research and
manufacturing problems in the microelectronics, biopharmaceutical
and analytical laboratory markets.
The matters discussed herein are forward-looking statements and
are based on current management expectations that involve
substantial risks and uncertainties (including the uncertainties
of litigation) which could cause actual outcomes to differ
materially from those expressed in, or implied by, these forward-
looking statements.
Potential risks and uncertainties that could affect the Company's
future operating results include, without limitation, foreign
exchange rates; increased regulatory concerns on the part of the
biopharmaceutical industry; further consolidation of drug
manufacturers; competitive factors such as new membrane
technology, and/or a new method of chip manufacture which relies
less heavily on purified chemicals and gases; availability of
component products on a timely basis; inventory risks due to
shifts in market demand; change in product mix; conditions in the
economy in general and in the microelectronics manufacturing
market in particular; the difficulty in integrating acquired
companies; potential environmental liabilities; the inability to
utilize technology in current or planned products due to
overriding rights by third parties, and the risk factors listed
from time to time in the Company's filings with the SEC.
To receive the latest information about Millipore via FAX, dial
(800) 758-5804 (PIN#101371). To access Millipore's Web site, go
to URL http:www.millipore.com.
